A Safety and Efficacy Trial of Multiple Dosing Regimens of ABT-719 for the Prevention of Acute Kidney Injury in Subjects Undergoing High Risk Surgery

PHASE2TerminatedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
Cardiothoracic SurgeryVascular Surgery
Interventions
DRUG

Placebo

Placebo infusion

DRUG

ABT-719

Arm 1 lower dose, arm 2 intermediate dose, arm 3 high dose

Trial Locations (23)

5000

Site Reference ID/Investigator# 105756, Odense C

6000

Site Reference ID/Investigator# 105757, Kolding

8200

Site Reference ID/Investigator# 105755, Aarhus N

10032

Site Reference ID/Investigator# 96996, New York

15232

Site Reference ID/Investigator# 97556, Pittsburgh

22908

Site Reference ID/Investigator# 108255, Charlottesville

27710

Site Reference ID/Investigator# 96296, Durham

32207

Site Reference ID/Investigator# 96778, Jacksonville

32610

Site Reference ID/Investigator# 96295, Gainesville

33613

Site Reference ID/Investigator# 96301, Tampa

38120

Site Reference ID/Investigator# 102019, Memphis

43210

Site Reference ID/Investigator# 103355, Columbus

44195

Site Reference ID/Investigator# 102020, Cleveland

46237

Site Reference ID/Investigator# 101961, Indianapolis

46804

Site Reference ID/Investigator# 96302, Fort Wayne

48073

Site Reference ID/Investigator# 99377, Royal Oak

48439

Site Reference ID/Investigator# 96997, Grand Blanc

49770

Site Reference ID/Investigator# 97878, Petoskey

53215

Site Reference ID/Investigator# 96300, Milwaukee

02115

Site Reference ID/Investigator# 103356, Boston

02135

Site Reference ID/Investigator# 96303, Boston

07052

Site Reference ID/Investigator# 99317, West Orange

02903

Site Reference ID/Investigator# 103316, Providence

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AbbVie

INDUSTRY